Citation

Chen X, Zou Y, Wang J, Cao Z, Liu J, Li Y, Zhao Y, He B. Bioorg. Med. Chem. 2020; 28(6): e115353.

Copyright

(Copyright © 2020, Elsevier Publishing)

DOI

10.1016/j.bmc.2020.115353

PMID

32061485

Abstract

A series of sirtuin inhibitor candidates were assembled based on an intermediate ester (1a) our accidently discovered. After screening and evaluation, several SIRT2 selective inhibitors were identified, which can inhibit all the deacetylation, defatty-acylation and debenzoylation of SIRT2. Among these inhibitors, compound 1e was the best SIRT2 selective inhibitors. The primary study on the inhibitory mechanism indicated that compound 1e may be a suicide inhibitor acting as an irreversible way. Given almost all reported sirtuin inhibitors are non-covalent, sirtuin covalent inhibitors are still need to be developed. These findings will facilitate for further development of SIRT2 selective and suicide inhibitors.

Language: en

Keywords

Humans; Dose-Response Relationship, Drug; Molecular Structure; Enzyme Inhibitors; Suicide inhibitors; Structure-Activity Relationship; Covalent inhibitors; Deacetylation; Deacylation; SIRT2; Sirtuin; Sirtuin 2; Small Molecule Libraries